Previous studies have shown that MMP8 inhibition can decrease the production of reactive oxygen species (ROS) and expression of inflammatory genes in conditions such as Parkinson’s disease and cerebral ischemia [13, 14], thereby reducing neuroinflammation. Here, MMP8 is linked to Parkinson disease.